Bionano Genomics, Inc.
corporate_fare Company Profile
Bionano Genomics, Inc. (NASDAQ:BNGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for BNGO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Bionano's OGM Studies Double at Key Genetics Meeting, Signaling Growing Adoption
- Bionano Genomics Discloses Going Concern Doubt Amid Preliminary Q4 & FY25 Results
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$28.51M
Net Income
-$26.39M
Diluted EPS
-$4.85
Op. Cash Flow
-$16.34M
Gross Profit
$13.19M
Operating Income
-$33.34M
Cash & Equivalents
$2.99M
Debt / Equity
0.00×
Net Margin
-92.6%
Shares Outstanding
10.74M sh
Source: 10-K · filed 2026-03-23 · accession 0001411690-26-000007
show_chartPrice Chart
Loading chart...